publication venue for
- Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS.. 17. 2022
- Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial.. 17. 2022
- Effect of Smoking and Its Cessation on the Transcript Profile of Peripheral Monocytes in COPD Patients.. 17. 2022
- CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care.. 16. 2021
- Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).. 16. 2021
- Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS.. 16. 2021
- Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort.. 15. 2020
- Novel Respiratory Disability Score Predicts COPD Exacerbations and Mortality in the SPIROMICS Cohort.. 15. 2020
- FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease.. 15. 2020
- Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies.. 15. 2020
- Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis.. 14. 2019
- Positive Expiratory Pressure Therapy With And Without Oscillation And Hospital Length Of Stay For Acute Exacerbation Of Chronic Obstructive Pulmonary Disease.. 14. 2019
- Effects of baseline symptom burden on treatment response in COPD.. 14. 2019
- Can CAPTURE be used to identify undiagnosed patients with mild-to-moderate COPD likely to benefit from treatment?. 13. 2018
- Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.. 11. 2016
- Phenotypic assessment of pulmonary hypertension using high-resolution echocardiography is feasible in neonatal mice with experimental bronchopulmonary dysplasia and pulmonary hypertension: a step toward preventing chronic obstructive pulmonary disease.. 11. 2016
- Mannose-binding lectin deficiency and acute exacerbations of chronic obstructive pulmonary disease.. 7. 2012
- Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? The REACT study protocol.. 7. 2012
- Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction.. 5. 2010
- Impact of social support and self-efficacy on functioning in depressed older adults with chronic obstructive pulmonary disease.. 3. 2008
- Respiratory disturbance during sleep in COPD patients without daytime hypoxemia.. 2. 2007
- Letter to Editor Regarding the OCEAN Study [Letter]. 2021
- Bronchodilator responsiveness or reversibility in asthma and COPD - a need for clarity.. 13. 2018
- High versus Medium Dose of Inhaled Corticosteroid in Chronic Obstructive Lung Disease: A Systematic Review and Meta-Analysis. 2023
- Focusing on outcomes: making the most of COPD interventions. 2009
- Identifying targets for COPD treatment through gene expression analyses. 2008
- Role of macrolide therapy in chronic obstructive pulmonary disease. 2008
- Pulmonary hypertension and chronic cor pulmonale in COPD. 2007
- Apoptotic mechanisms in the pathogenesis of COPD. 2006